CAR- T and cell genetics treatments are also pricey

.Mother Nature Medication, Published online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care production as well as technology move may deliver cell gene therapies at an economical expense to patients around the world.